Source:http://linkedlifedata.com/resource/pubmed/id/17847023
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-11-1
|
pubmed:abstractText |
K-ras and mucin profile variations, associated with intestinal carcinogenesis, were studied in the preneoplastic lesions, mucin-depleted foci (MDF) and aberrant crypt foci (ACF), and in colonic tumors induced in rats by 1,2-dimethylhydrazine (DMH). The frequency of lesions with K-ras mutations was 23% (3/13), 5.5% (1/18) and 100% (14/14) in MDF, tumors and ACF, respectively. Two of three MDF mutated in K-ras also carried a missense mutation in Apc. We also tested the expression of MUC2, a mucin abundantly expressed in normal colon and M1/MUCA5C, up-regulated in colon carcinogenesis, using immunohistochemistry. MDF and tumors showed a dramatic reduction in the expression of MUC2, whereas ACF showed only a slight reduction. The expression of M1/MUC5AC was almost absent in normal mucosa, but was increased in all the lesions (MDF, tumors and ACF). The expression of the intestinal trefoil factor (ITF), a marker of goblet cell lineage, was reduced in MDF and tumors compared to normal mucosa but not in ACF. In conclusion, although K-ras mutations are present in all ACF, they are less frequent in MDF and tumors; M1/MUC5AC is a marker associated with all preneoplastic events while the reduction of MUC2 and ITF expression is selectively associated with more advanced lesions such as MDF and tumors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1,2-Dimethylhydrazine,
http://linkedlifedata.com/resource/pubmed/chemical/Mucins,
http://linkedlifedata.com/resource/pubmed/chemical/Mutagens,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/trefoil factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1097-0215
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2007 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
122
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
117-23
|
pubmed:meshHeading |
pubmed-meshheading:17847023-1,2-Dimethylhydrazine,
pubmed-meshheading:17847023-Animals,
pubmed-meshheading:17847023-Cell Transformation, Neoplastic,
pubmed-meshheading:17847023-Colonic Neoplasms,
pubmed-meshheading:17847023-Genes, APC,
pubmed-meshheading:17847023-Genes, ras,
pubmed-meshheading:17847023-Immunoenzyme Techniques,
pubmed-meshheading:17847023-Male,
pubmed-meshheading:17847023-Mucins,
pubmed-meshheading:17847023-Mutagens,
pubmed-meshheading:17847023-Mutation,
pubmed-meshheading:17847023-Peptides,
pubmed-meshheading:17847023-Precancerous Conditions,
pubmed-meshheading:17847023-Rats,
pubmed-meshheading:17847023-Rats, Inbred F344
|
pubmed:year |
2008
|
pubmed:articleTitle |
K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine.
|
pubmed:affiliation |
Department of Pharmacology, University of Florence, Florence, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|